Información del producto
AZD-8529 is a potentiating agent of metabotropic glutamate receptors. It is a mesylate prodrug that is converted to the active form, AZD-8529-mesylate, in vivo. The conversion is catalyzed by esterases and glucuronidases. AZD-8529 has been shown to be safe and well tolerated in patients with schizophrenia who were treated for 4 weeks with a daily dose of 600 mg or 900 mg. It also has a potentiating effect on metabotropic glutamate receptors, which may lead to increased signaling of these receptors in the brain. This may lead to improved cognition and mental health in patients with schizophrenia or other mental disorders.
Propiedades químicas
Consulta técnica sobre: 3D-STB45315 AZD-8529
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
